Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -34,945 | -96,322 | -16,705 | -53,909 |
| Depreciation Amortization | 573 | 1,913 | 495 | 1,540 |
| Income taxes - deferred | -206 | N/A | N/A | N/A |
| Accounts receivable | 98 | N/A | N/A | N/A |
| Other Working Capital | -2,195 | -6,678 | -2,074 | -1,412 |
| Other Operating Activity | 2,451 | 6,122 | 330 | 1,459 |
| Operating Cash Flow | $-34,224 | $-94,965 | $-17,954 | $-52,322 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2,280 | -2,387 | -552 | -2,977 |
| Purchase Sale Intangibles | N/A | N/A | -9 | N/A |
| Other Investing Activity | 0 | -1 | -9 | -45 |
| Investing Cash Flow | $-2,280 | $-2,388 | $-561 | $-3,022 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | N/A | N/A | 1,183 | N/A |
| Other Financing Activity | 0 | 242,620 | 0 | 114,589 |
| Financing Cash Flow | $N/A | $242,620 | $1,183 | $114,589 |
| Exchange Rate Effect | 2,142 | 11,738 | -3,961 | -1,014 |
| Beginning Cash Position | 231,576 | 74,571 | 74,571 | 16,340 |
| End Cash Position | 197,214 | 231,576 | 53,278 | 74,571 |
| Net Cash Flow | $-34,362 | $157,005 | $-21,293 | $58,231 |
| Free Cash Flow | ||||
| Operating Cash Flow | -34,224 | -94,965 | -17,954 | -52,322 |
| Capital Expenditure | -2,280 | N/A | -552 | N/A |
| Free Cash Flow | -36,504 | -94,965 | -18,506 | -52,322 |